###begin article-title 0
###xml 41 46 41 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 112 117 112 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 119 126 119 126 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15,</italic>
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">OCTN1/2</italic>
###xml 81 89 <span type="species:ncbi:9606">Patients</span>
rs1004819 Is the Main Disease-Associated IL23R Variant in German Crohn's Disease Patients: Combined Analysis of IL23R, CARD15, and OCTN1/2 Variants
###end article-title 0
###begin p 1
Conceived and designed the experiments: SB JG JS. Performed the experiments: JG MW SS LT CG JD KM PL. Analyzed the data: BM SB JG JS MW HT SP WK JE. Contributed reagents/materials/analysis tools: SB JG JS AK HT TG WK JE US CF PL BG TO MF TM. Wrote the paper: SB JG JS PL. Other: Organized collaboration between the different institutions: SB.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 309 314 309 314 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
The IL23R gene has been identified as a susceptibility gene for inflammatory bowel disease (IBD) in the North American population. The aim of our study was to test this association in a large German IBD cohort and to elucidate potential interactions with other IBD genes as well as phenotypic consequences of IL23R variants.
###end p 3
###begin title 4
Methods
###end title 4
###begin p 5
###xml 193 198 193 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 311 318 311 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4</italic>
###xml 342 349 340 347 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A5</italic>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 98 106 <span type="species:ncbi:9606">patients</span>
Genomic DNA from 2670 Caucasian individuals including 833 patients with Crohn's disease (CD), 456 patients with ulcerative colitis (UC), and 1381 healthy unrelated controls was analyzed for 10 IL23R SNPs. Genotyping included the NOD2 variants p.Arg702Trp, p.Gly908Arg, and p.Leu1007fsX1008 and polymorphisms in SLC22A4/OCTN1 (1672 C-->T) and SLC22A5/OCTN2 (-207 G-->C).
###end p 5
###begin title 6
Results
###end title 6
###begin p 7
###xml 4 9 4 9 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 143 144 143 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 154 157 154 157 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 302 303 302 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 403 404 403 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 414 416 414 416 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 543 548 543 548 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 586 592 586 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15</italic>
###xml 597 606 597 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4/5</italic>
All IL23R gene variants analyzed displayed highly significant associations with CD. The strongest association was found for the SNP rs1004819 [P = 1.92x10-11; OR 1.56; 95 % CI (1.37-1.78)]. 93.2% of the rs1004819 TT homozygous carriers as compared to 78% of CC wildtype carriers had ileal involvement [P = 0.004; OR 4.24; CI (1.46-12.34)]. The coding SNP rs11209026 (p.Arg381Gln) was protective for CD [P = 8.04x10-8; OR 0.43; CI (0.31-0.59)]. Similar, but weaker associations were found in UC. There was no evidence for epistasis between the IL23R gene and the CD susceptibility genes CARD15 and SLC22A4/5.
###end p 7
###begin title 8
Conclusion
###end title 8
###begin p 9
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 75 81 75 81 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15</italic>
###xml 86 95 86 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4/5</italic>
###xml 120 125 120 125 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 201 206 201 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
IL23R is an IBD susceptibility gene, but has no epistatic interaction with CARD15 and SLC22A4/5. rs1004819 is the major IL23R variant associated with CD in the German population, while the p.Arg381Gln IL23R variant is a protective marker for CD and UC.
###end p 9
###begin title 10
Introduction
###end title 10
###begin p 11
###xml 292 295 292 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Podolsky1">[1]</xref>
###xml 297 300 297 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Sartor1">[2]</xref>
###xml 330 336 330 336 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15</italic>
###xml 401 404 401 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Ogura1">[3]</xref>
###xml 406 409 406 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Hugot1">[4]</xref>
###xml 544 547 544 547 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Brand1">[5]</xref>
###xml 549 552 549 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Brand2">[6]</xref>
###xml 554 557 554 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Dambacher1">[7]</xref>
###xml 559 562 559 562 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Peltekova1">[8]</xref>
###xml 564 567 564 567 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Schnitzler1">[9]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Torok1">[10]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Glas1">[11]</xref>
Inflammatory bowel diseases (IBD) such as Crohn's disease (CD) and ulcerative colitis (UC) are chronic inflammatory disorders of the gastrointestinal tract characterized by a perpetuated mucosal immune response which is triggered by intestinal bacteria in genetically susceptible individuals [1], [2]. Since the identification of CARD15 (encoding NOD2) as the first susceptibility gene for CD in 2001 [3], [4], several variants of proteins involved in bacterial recognition were demonstrated to be associated with IBD or certain IBD phenotypes [5], [6], [7], [8], [9], [10], [11].
###end p 11
###begin p 12
###xml 28 32 28 32 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 48 53 48 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 383 387 383 387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 417 422 417 422 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 521 525 521 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 575 579 575 579 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Tremelling1">[13]</xref>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Dubinsky1">[14]</xref>
###xml 607 611 607 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-VanLimbergen1">[15]</xref>
###xml 656 661 656 661 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 711 718 711 718 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL12RB2</italic>
###xml 738 742 738 742 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 866 870 866 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
Most recently, Duerr et al. [12] identified the IL23R gene located on chromosome 1p31 as an IBD susceptibility gene in a genome-wide association study testing 308,332 single nucleotide polymorphisms (SNPs) in 547 non-Jewish ileal CD cases and 548 controls. Subsequent analyses by the same group confirmed these findings in an independent Jewish CD cohort and in 883 nuclear families [12]. In this study, the uncommon IL23R coding variant rs11209026 (1142G>A; p.Arg381Gln) was associated with strong protection against CD [12]. This was recently confirmed in a British cohort [13] and for pediatric CD [14], [15]. For nine other variants located within the IL23R gene or in the intergenic area with the adjacent IL12RB2 gene, Duerr et al. [12] demonstrated associations with CD with p-values of <0.0001. Some of these variants also showed weaker associations with UC [12].
###end p 12
###begin p 13
###xml 369 373 366 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Veldhoen1">[16]</xref>
###xml 442 446 439 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Zhou1">[17]</xref>
###xml 448 452 445 449 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Korn1">[18]</xref>
###xml 454 458 451 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Nurieva1">[19]</xref>
###xml 1492 1496 1477 1481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Neurath1">[20]</xref>
###xml 1624 1628 1609 1613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Yen1">[21]</xref>
###xml 1630 1634 1615 1619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Becker1">[22]</xref>
###xml 1636 1640 1621 1625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Hue1">[23]</xref>
###xml 1750 1754 1735 1739 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Langowski1">[24]</xref>
###xml 1756 1760 1741 1745 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Hao1">[25]</xref>
###xml 1864 1868 1849 1853 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Thakker1">[26]</xref>
###xml 1909 1913 1894 1898 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-VakninDembinsky1">[27]</xref>
###xml 2072 2076 2057 2061 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Elson1">[28]</xref>
###xml 1611 1616 <span type="species:ncbi:10090">mouse</span>
###xml 1680 1685 <span type="species:ncbi:9606">human</span>
###xml 1745 1749 <span type="species:ncbi:10090">mice</span>
###xml 1852 1857 <span type="species:ncbi:10090">mouse</span>
###xml 1876 1884 <span type="species:ncbi:9606">patients</span>
###xml 2057 2063 <span type="species:ncbi:10090">murine</span>
IL-23, a member of the IL-12 cytokine family, represents a proinflammatory cytokine and is composed of the IL-23-specific p19 subunit and a p40 subunit, which is also part of the IL-12 heterodimer. IL-23, mainly produced by activated macrophages and dendritic cells (DCs), activates Th17 cells which differentiate under the influence of the cytokines IL-6 and TGF-beta [16]. Very recent studies indicate also a role for IL-21 in this process [17], [18], [19]. In Th17 cells, the transcription factor RORgammat activates the expression of proinflammatory Th17 cytokines such as IL-17A, IL-17F and IL-22. In contrast, IL-12 induces the differentiation of naive CD4+ T cells into IFN-gamma producing Th1 cells through activation of STAT4. IFN-gamma induced signals are transduced by STAT1, which activates a downstream transcription factor, T-bet, which enhances the expression of genes specific to Th1 cells. Th1 cells promote a cell-mediated immune response to intracellular pathogens, while IL-4-, IL-5- and IL-13-producing Th2 cells promote a humoral immune response to extracellular pathogens. Similarly, there is increasing evidence for the IL-23/IL-17 axis as a key pathway in the development of chronic inflammation and in host defense against bacterial infection, promoting local tissue inflammation by stimulating T cells, macrophages and fibroblasts as well as endothelial and epithelial cells to produce proinflammatory cytokines, metalloproteinases, and chemokines (reviewed in Ref.[20]). Recent studies demonstrated a critical role for the IL-23/IL-17 pathway in T-cell mediated colitis in different mouse models [21], [22], [23], in tumour immunity as demonstrated in human tumor tissues and cancer cell lines as well as in knockout mice [24], [25], and in the development of autoimmune diseases including autoimmune encephalomyelitis in a mouse model [26] and in patients with multiple sclerosis [27]. A very recent study demonstrated that monoclonal antibodies (mAb) directed against IL-23 reverse active colitis in a T cell-mediated model of murine colitis [28].
###end p 13
###begin p 14
###xml 74 78 74 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Neurath1">[20]</xref>
###xml 80 84 80 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Becker1">[22]</xref>
###xml 86 90 86 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Fuss1">[29]</xref>
###xml 152 156 152 156 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 349 353 349 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Becker2">[30]</xref>
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Niess1">[31]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Waibler1">[32]</xref>
###xml 819 823 819 823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Fuss1">[29]</xref>
###xml 899 903 899 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Fuss1">[29]</xref>
###xml 1036 1040 1036 1040 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Mizoguchi1">[33]</xref>
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
###xml 65 70 <span type="species:ncbi:9606">human</span>
###xml 749 757 <span type="species:ncbi:9606">patients</span>
###xml 851 859 <span type="species:ncbi:9606">patients</span>
###xml 953 958 <span type="species:ncbi:10090">mouse</span>
The strong expression of IL-23 in ileal DCs in a mouse model and human CD [20], [22], [29] and the recent findings of the genome-wide association study [12] suggest that the IL-23/IL-23R cytokine receptor system is also involved in the pathogenesis of CD. Interestingly, IL-23 secretion in ileal DCs is driven by the intestinal bacterial microflora [30], and we recently demonstrated that ileal DCs may actively sample luminal bacteria via dendrites reaching the intestinal lumen [31]. However, only myeloid DCs and not plasmacytoid DCs secreted IL-23 upon stimulation with various toll-like receptor (TLR) ligands [32]. Increased IL-23 secretion has been shown in antigen-presenting cells (APCs) derived from lamina propria mononuclear cells of CD patients which could be down-regulated by anti-IL-12p40 mAb treatment [29]. In contrast, APCs from UC patients produced only baseline levels of IL-23 [29]. Moreover, a very recent study demonstrated in a mouse model that IL-23 producing DCs participate in intestinal granuloma formation [33] further pointing to a role for this cytokine in the pathogenesis of CD.
###end p 14
###begin p 15
###xml 156 160 156 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Cardon1">[34]</xref>
###xml 230 235 230 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 401 407 401 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL-23R</italic>
###xml 504 508 504 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 570 576 570 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15</italic>
###xml 591 594 591 594 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Ogura1">[3]</xref>
###xml 596 599 596 599 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Hugot1">[4]</xref>
###xml 601 605 601 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Hampe1">[35]</xref>
###xml 619 626 619 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4</italic>
###xml 723 731 723 731 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A5,</italic>
###xml 747 750 747 750 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Peltekova1">[8]</xref>
###xml 752 756 752 756 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Torok1">[10]</xref>
###xml 758 762 758 762 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Noble1">[36]</xref>
###xml 877 881 877 881 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Torok1">[10]</xref>
###xml 883 887 883 887 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Seiderer1">[37]</xref>
###xml 889 893 889 893 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Seiderer2">[38]</xref>
###xml 950 955 950 955 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 1099 1104 1099 1104 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
Since replication of genome-wide association findings in populations with different genetic background is essential to confirm disease susceptibility genes [34] and in order to clarify the phenotypic consequences of the different IL23R variants in IBD, we performed a detailed genotype-phenotype analysis in a large German IBD cohort (CD: n = 833; UC: n = 456; controls: n = 1289) by analyzing all 10 IL-23R variants for which significant linkage to CD has been demonstrated in the study by Duerr et al. [12]. In addition, we tested for epistasis of IL23R variants with CARD15 gene variants [3], [4], [35], and SNPs in SLC22A4 (solute carrier family 22, member 4), encoding the organic cation transporter 1 (OCTN1), and in SLC22A5, encoding OCTN2 [8], [10], [36]. Since these gene variants are proven CD susceptibility genes associated with distinct phenotypic characteristics [10], [37], [38], our aim was to investigate potential interactions with IL23R variants including epistatic effects on certain disease phenotypes. In a detailed genotype-phenotype analysis, we also analyzed the effects of IL23R variants on specific CD and UC disease subtypes.
###end p 15
###begin title 16
Methods
###end title 16
###begin title 17
Study population
###end title 17
###begin p 18
###xml 807 814 807 814 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t001">Table 1</xref>
###xml 959 963 959 963 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-LennardJones1">[39]</xref>
###xml 1037 1041 1037 1041 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Silverberg1">[40]</xref>
###xml 58 66 <span type="species:ncbi:9606">patients</span>
###xml 101 109 <span type="species:ncbi:9606">patients</span>
###xml 123 131 <span type="species:ncbi:9606">patients</span>
###xml 227 235 <span type="species:ncbi:9606">patients</span>
###xml 359 364 <span type="species:ncbi:9606">Human</span>
###xml 575 582 <span type="species:ncbi:9606">patient</span>
###xml 965 973 <span type="species:ncbi:9606">Patients</span>
###xml 1124 1132 <span type="species:ncbi:9606">patients</span>
###xml 1319 1327 <span type="species:ncbi:9606">Patients</span>
The study population (n = 2670) was comprised of 1289 IBD patients of Caucasian origin including 833 patients with CD, 456 patients with UC, and 1381 healthy, unrelated controls. Written, informed consent was obtained from all patients. The study was approved by the local Ethics committee and adhered to the Ethical Principles for Medical Research Involving Human Subjects of the Helsinki Declaration (). Demographic and clinical data (behaviour and location of IBD, disease-related complications, need for surgery or immunosuppressive therapy) were recorded by analysis of patient charts and a detailed questionnaire including an interview at time of enrolment. The demographic characteristics of the IBD study population were collected blind to the results of the genotype analyses and are summarized in Table 1. The diagnosis of CD or UC was determined according to established guidelines based on endoscopic, radiological, and histopathological criteria [39]. Patients with CD were assessed according to the Montreal classification [40] based on the age at diagnosis (A), location (L), and behaviour (B) of disease. In patients with UC, anatomic location was also based on the Montreal classification, using the criteria ulcerative proctitis (E1), left-sided UC (distal UC; E2), and extensive UC (pancolitis; E3). Patients with indeterminate colitis were excluded from the study.
###end p 18
###begin title 19
Demographic characteristics of the IBD study population.
###end title 19
###begin title 20
DNA extraction and genotyping of the IL23R variants
###end title 20
###begin p 21
###xml 148 153 148 153 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 364 368 364 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 1557 1565 1537 1545 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000819.s001">table S1</xref>
###xml 2224 2233 2174 2183 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000819.s001">Tables S1</xref>
###xml 2238 2240 2188 2190 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000819.s002">S2</xref>
Genomic DNA was isolated from peripheral blood leukocytes by standard procedures using the DNA blood mini kit from Qiagen (Hilden, Germany). The 10 IL23R SNPs (rs1004819, rs7517847, rs10489629, rs2201841, rs11465804, rs11209026 = p.Arg381Gln, rs1343151, rs10889677, rs11209032, rs1495965), for which significant associations with CD were found in a previous study [12], were genotyped by PCR and melting curve analysis using a pair of fluorescence resonance energy transfer (FRET) probes in a LightCycler(R) 480 Instrument (Roche Diagnostics, Mannheim, Germany). The donor fluorescent molecule (fluorescein) at the 3'-end of the sensor probe is excited at its specific fluorescence excitation wavelength (533 nm) and the energy is transferred to the acceptor fluorescent molecule at the 5'-end of the anchor probe (LightCycler Red 610, 640, or 670). The specific fluorescence signal emitted by the acceptor molecule is detected by the LightCycler(R) 480 Instrument. The sensor probe matches exactly to one allele of each SNP, preferentially to the less common allele, whereas, in the case of the other allele, there is a mismatch resulting in a lower melting temperature. The total volume of the PCR was 5 microl containing 25 ng of genomic DNA, 1xLight Cycler 480 Genotyping Master (Roche Diagnostics), 2.5 pmol of each primer, and 0.75 pmol of each FRET probe (TIB MOLBIOL, Berlin, Germany). Amplification included an initial denaturation step (95degreesC for 10 min) followed by 45 cycles (95degreesC for 10 sec, primer annealing temperature as given in table S1 for 10 sec, 72degreesC for 15 sec). The melting curve analysis was comprised of an initial denaturation step (95degreesC for 1 min), a step rapidly lowering the temperature to 40degreesC and holding for 30 sec, and a heating step slowly increasing the temperature up to 80degreesC and continuously measuring the fluorescence intensity (1 acquisition/degreesC). The results of the melting curve analysis were confirmed by analyzing samples representing all possible genotypes using sequence analysis. All sequences of primers and FRET probes and primer annealing temperatures used for genotyping and for sequence analysis are given in the Supplementary data (Tables S1 and S2).
###end p 21
###begin title 22
Genotyping of the CARD15 and OCTN1/2 variants
###end title 22
###begin p 23
###xml 166 169 166 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Schnitzler1">[9]</xref>
###xml 206 213 204 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4</italic>
###xml 279 286 275 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A5</italic>
###xml 397 401 393 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Torok1">[10]</xref>
Genotyping of the three common NOD2 variants p.Arg702Trp (rs2066844), p.Gly908Arg (rs2066847), and p.Leu1007fsX1008 (rs2066847) was performed as described previously [9]. In addition, the 1672 C-->T SNP in SLC22A4 (rs1050152) encoding OCTN1 and the -207 G-->C SNP (rs2631367) in SLC22A5 encoding OCTN2 were investigated by restriction fragment length polymorphism analysis as described previously [10] or by melting curve analysis using FRET probes (primer and probe sequences are available on request).
###end p 23
###begin title 24
Statistical analyses
###end title 24
###begin p 25
###xml 161 162 159 160 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
###xml 257 258 253 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sup>
Each genetic marker was tested for Hardy-Weinberg equilibrium in the control population. For comparison between categorical variables, Fisher's exact test or Chi2 test was used where appropriate. Single-marker allelic tests were performed with Pearson's Chi2 test. Student's t-test was applied for quantitative variables. All tests were two-tailed, considering p-values <0.05 as significant. Odds ratios were calculated for the minor allele at each SNP. For multiple comparisons, Bonferroni correction was applied. Data were evaluated by using the SPSS 13.0 software (SPSS Inc., Chicago, IL, USA) and R-2.4.1. (). Interactions between different polymorphisms were tested using logistic regression in R testing using the number of minor alleles as predictor variable thus implementing an Armitage test of trend.
###end p 25
###begin title 26
Results
###end title 26
###begin title 27
Frequency distribution of IL23R genotypes and their role in IBD susceptibility
###end title 27
###begin p 28
###xml 82 87 82 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 153 158 153 158 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 256 258 256 258 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;5</sup>
###xml 269 272 269 272 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 274 281 274 281 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t002">Table 2</xref>
###xml 359 364 359 364 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 419 427 419 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000819.s003">Table S3</xref>
###xml 495 496 495 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 506 509 506 509 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 674 678 674 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 851 852 851 852 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 862 864 862 864 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 896 903 896 903 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t002">Table 2</xref>
###xml 1167 1172 1167 1172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 734 742 <span type="species:ncbi:9606">patients</span>
In all three subgroups (CD, UC, and controls), the genotype frequencies of the 10 IL23R SNPs were in accordance with the Hardy-Weinberg equilibrium. All IL23R gene variants displayed highly significant associations with CD. The P-values ranged from 4.36x10-5 to 1.92x10-11 (Table 2). The distribution of wildtype, heterozygous and homozygous carriers of each IL23R variant in CD and UC compared to controls is given in Table S3. In CD, the strongest association was found for the SNP rs1004819 [P = 1.92x10-11; OR 1.56; 95 % CI (1.37-1.78)]. The allele frequencies for the SNP rs11209026 (p.Arg381Gln), which displayed the strongest association in the study of Duerr et al. [12], showed also highly significant differences between CD patients and controls in our study. The minor allele frequency was 0.030 in CD as compared to 0.068 in the controls [P = 8.04x10-8; OR 0.43; 95 % CI (0.31-0.59); Table 2], suggesting a protective effect against CD. By combining both SNPs in a logistic regression analysis, we were able to demonstrate independent effects on CD susceptibility. An additional independent effect could also be shown for rs7517847, while the other seven IL23R SNPs were not independently disease-associated.
###end p 28
###begin title 29
###xml 16 21 16 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
Associations of IL23R gene markers in CD and UC case-control association studies.
###end title 29
###begin p 30
###xml 45 46 45 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Minor allele frequencies (MAF), allelic test P-values, and odds ratios (OR, shown for the minor allele) with 95% confidence intervals (CI) are depicted for both the CD and UC case-control cohorts.
###end p 30
###begin p 31
###xml 39 44 39 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 166 171 166 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 247 254 247 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t002">Table 2</xref>
###xml 435 442 435 442 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t002">Table 2</xref>
###xml 515 520 515 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 595 596 595 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 606 608 606 608 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;4</sup>
###xml 831 832 831 832 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 842 844 842 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;2</sup>
###xml 906 913 906 913 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t002">Table 2</xref>
###xml 952 957 952 957 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 1070 1071 1070 1071 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1081 1083 1081 1083 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;3</sup>
###xml 1215 1220 1215 1220 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 742 750 <span type="species:ncbi:9606">patients</span>
In contrast to CD, the associations of IL23R SNPs with susceptibility to UC were markedly weaker. However, with the exception of rs11465804 and rs11209032, all other IL23R variants were significantly associated with UC in the univariate analysis (Table 2). For these eight SNPs, the odds ratios differentiating between protection against UC (OR<1.0) or increased UC susceptibility (OR>1.0), were very similar to those observed for CD (Table 2), suggesting overall similar disease-modifying effects of the different IL23R variants on CD and UC. The most strongly UC-associated SNP was rs7517847 [P = 3.78x10-4; OR = 0.76; 95 % CI (0.65-0.88)]. Similar to CD, the frequency of the SNP rs11209026 (p.Arg381Gln) was significantly decreased in UC patients compared to the controls, although this association was much weaker than in CD [P = 3.61x10-2; OR = 0.70; 95 % CI (0.50-0.98)] in the univariate analysis (Table 2). While the minor allele of these two IL23R variants protected against UC, the minor allele of rs1004819 was associated with UC in the univariate analysis [P = 3.81x10-3; OR = 1.27; 95 % CI (1.08-1.50)]. Comparing only SNPs with ORs>1.0 in this analysis, rs1004819 was the most strongly UC-associated IL23R variant, similar to our results in CD. However, stepwise forward logistic regression analysis revealed only rs7517847 as an independent risk factor for UC.
###end p 31
###begin title 32
Associations between IL23R genotype and IBD phenotype
###end title 32
###begin p 33
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 147 152 147 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 235 242 235 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t003">Table 3</xref>
###xml 339 344 339 344 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 598 602 598 602 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Silverberg1">[40]</xref>
###xml 763 770 763 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t003">Table 3</xref>
###xml 948 949 948 949 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 198 206 <span type="species:ncbi:9606">patients</span>
###xml 288 296 <span type="species:ncbi:9606">patients</span>
###xml 368 376 <span type="species:ncbi:9606">patients</span>
Having confirmed that IL23R is an IBD susceptibility gene also in the German population, we next investigated potential phenotypic consequences of IL23R variants in a well-characterized subgroup of patients from the Munich IBD center. Table 3 summarizes the disease characteristics of CD patients depending on the rs11209026 (p.Arg381Gln) IL23R genotype status. In CD patients with different rs11209026 (p.Arg381Gln) genotypes, there were no differences in the frequency of disease characteristics such as age of onset, disease behaviour, disease location as defined by the Montreal classification [40], extraintestinal involvement, and other complications of CD such as incidence of stenoses, fistulas, abscess formation, or the use of immunosuppressive agents (Table 3), although there was a trend towards less surgical interventions in carriers of the A allele of the p.Arg381Gln variant, which, however, did not reach statistical significance [P = 0.067; OR 0.39; CI (0.15-1.05)]. A subgroup analysis based on the type of surgery (e.g., stricturoplasty, ileocecal resection, fistulectomy, colectomy) did not demonstrate significant associations to a certain type of surgical intervention nor to a certain cause of surgery, e.g., ileal stenosis (data not shown). However, this analysis was limited by the fact that the subgroup analyzed for phenotypic consequences did not contain AA homozygous carriers of the rs11209026 (p.Arg381Gln) variant.
###end p 33
###begin title 34
###xml 20 25 20 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 215 219 215 219 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Silverberg1">[40]</xref>
Association between IL23R p.Arg381Gln (rs11209026) genotype and CD disease characteristics in the subcohort of the Munich IBD center (n = 452) for which detailed phenotypic data based on the Montreal classification [40] were available.
###end title 34
###begin p 35
###xml 33 41 <span type="species:ncbi:9606">patients</span>
For each variable, the number of patients included is given.
###end p 35
###begin p 36
In this subgroup, there were no AA homozygous carriers for the genotype-phenotype analysis available.
###end p 36
###begin p 37
###xml 71 75 71 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Silverberg1">[40]</xref>
Disease behaviour was defined according to the Montreal classification [40]. A stricturing disease phenotype was defined as presence of stenosis without penetrating disease. The diagnosis of stenosis was made surgically, endoscopically, or radiologically (using MRI enteroclysis).
###end p 37
###begin p 38
Immunosuppressive agents included azathioprine, 6-mercaptopurine, 6-thioguanin, methotrexate, and/or infliximab.
###end p 38
###begin p 39
Only surgery related to CD-specific problems (e.g. fistulectomy, colectomy, ileostomy) was included.
###end p 39
###begin p 40
###xml 55 60 55 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 260 261 260 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 297 304 297 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t004">Table 4</xref>
###xml 548 555 548 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t004">Table 4</xref>
Analyzing the phenotypic contribution of the rs1004819 IL23R variant, which had overall the most significant association with CD, there was an increased incidence of ileal involvement in TT homozygous carriers (93.2%) compared to CC wildtype carriers (78.0%) [P = 0.004; OR 4.24; CI (1.46-12.34); Table 4] which, however, lost significance after Bonferroni correction. Similarly, there was an increased incidence of stenosis in rs1004819 TT homozygotes compared to carriers of the CC genotype [(74.6% vs. 59.6%; P = 0.045; OR 1.99; CI (1.04-3.82); Table 4] which also did not fulfill the criteria of significance after Bonferroni correction. Moreover, the variant rs7517847, for which we demonstrated an association with UC in the stepwise logistic regression analysis, was not associated with any specific disease subtype (data not shown).
###end p 40
###begin title 41
###xml 21 26 21 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 206 210 206 210 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Silverberg1">[40]</xref>
Associations between IL23R SNP rs1004819 genotypes and CD disease characteristics in the subcohort of the Munich IBD center (n = 457) for which detailed phenotypic data based on the Montreal classification [40] were available.
###end title 41
###begin p 42
###xml 12 13 12 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 316 323 316 323 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t003">Table 3</xref>
###xml 247 255 <span type="species:ncbi:9606">patients</span>
Significant P-values are given in bold letters including corresponding odds ratios (OR) and 95% confidence intervals (CI). However, none of these P-values remained significant after Bonferroni correction (P>0.05). For each variable, the number of patients with a complete data set is given. Footnotes: See legend of Table 3 for detailed explanation.
###end p 42
###begin title 43
###xml 71 79 <span type="species:ncbi:9606">patients</span>
Analysis for epistasis between IL23R, CARD15 and SLC22A4/5 genes in CD patients
###end title 43
###begin p 44
###xml 57 62 57 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 129 135 129 135 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15</italic>
###xml 135 138 135 138 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Ogura1">[3]</xref>
###xml 140 143 140 143 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Hugot1">[4]</xref>
###xml 145 149 145 149 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Hampe1">[35]</xref>
###xml 151 159 151 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4,</italic>
###xml 164 171 164 171 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A5</italic>
###xml 171 174 171 174 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Peltekova1">[8]</xref>
###xml 176 180 176 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Torok1">[10]</xref>
###xml 182 186 182 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Noble1">[36]</xref>
###xml 417 424 417 424 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4</italic>
###xml 445 452 443 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A5</italic>
###xml 534 541 530 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A5</italic>
###xml 613 620 607 614 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="pone-0000819-t005">Table 5</xref>
###xml 697 702 691 696 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 734 735 728 729 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">.</bold>
###xml 748 749 742 743 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 829 830 823 824 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1123 1131 1117 1125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000819.s004">Table S4</xref>
###xml 1136 1138 1130 1132 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000819.s005">S5</xref>
###xml 1223 1224 1217 1218 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1258 1259 1252 1253 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Finally, we analyzed potential evidence for epistasis of IL23R variants with the other three replicated IBD susceptibility genes CARD15[3], [4], [35], SLC22A4, and SLC22A5[8], [10], [36] including their effects on overall disease susceptibility and phenotype. In all three subgroups (CD, UC, and controls), the frequencies of the analyzed NOD2 variants (p.Arg702Trp, p.Gly908Arg, p.Leu1007fsX1008) and of the SNPs in SLC22A4 (1672 C-->T) and in SLC22A5 (-207 G-->C) were in accordance with the Hardy-Weinberg equilibrium. Except from SLC22A5 (-207 G-->C), all SNPs were highly associated with CD but not with UC (Table 5). No evidence for epistasis between these three CD susceptibility genes and IL23R variants was found in CD and UC. None of the P-values found was significant after correction for multiple testing; the lowest P-value for CD was 0.147 for the interaction between rs11209026 and NOD2 mutation status with an associated OR of 1.33 [CI (0.92-1.91)]. There was evidence for epistatic gene-gene interactions regarding several phenotypic disease characteristics which are summarized in the Supplementary Data (Table S4 and S5). However, given the large number of interactions analyzed (n = 364), none of these P values remained significant at a P level of <0.05 after Bonferrroni correction.
###end p 44
###begin title 45
###xml 15 21 15 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15</italic>
###xml 23 30 23 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4</italic>
###xml 35 42 35 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A5</italic>
Association of CARD15, SLC22A4 and SLC22A5 variants with CD (n = 833) and UC (n = 456) compared to the control population (n = 1381).
###end title 45
###begin p 46
OR: odds ration; 95% CI: 95% confidence interval.
###end p 46
###begin title 47
Discussion
###end title 47
###begin p 48
###xml 67 72 67 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 303 308 303 308 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 383 399 383 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15, SLC22A4,</italic>
###xml 404 411 404 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A5</italic>
###xml 526 530 526 530 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 897 901 897 901 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 117 124 <span type="species:ncbi:9606">patient</span>
###xml 229 237 <span type="species:ncbi:9606">patients</span>
The present study confirms the previously described association of IL23R gene variants with CD in a large German IBD patient cohort and demonstrates a particular role for the rs1004819 variant in the pathogenesis of CD in German patients. It is the first study analyzing for potential epistasis between IL23R variants and the three other previously described CD susceptibility genes CARD15, SLC22A4, and SLC22A5. Our results also verify the previously identified role of rs11209026 (p.Arg381Gln) as a protective variant in CD [12]. The greatest influence on the disease risk for CD was seen in homozygous carriers of the minor allele of the rs1004819 and rs11209026 (p.Arg381Gln) gene variants with an odds ratio of 2.46 and 0.41, respectively, compared to healthy controls, demonstrating opposing effects of these two SNPs on CD susceptibility. By confirming the results obtained by Duerr et al. [12], our study supports the validity of chip-based technologies for the rapid identification of disease susceptibility genes in genome-wide association studies.
###end p 48
###begin p 49
###xml 154 158 154 158 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 240 244 240 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Rioux1">[41]</xref>
###xml 418 422 418 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Tremelling1">[13]</xref>
###xml 569 573 569 573 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Libioulle1">[42]</xref>
###xml 606 611 606 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 681 686 681 686 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 89 96 <span type="species:ncbi:9606">patient</span>
The identification of rs1004819 as an independent major CD susceptibility variant in our patient cohort contrasts with the data published by Duerr et al. [12] and those of a related study with an overlapping North American study population [41], in which rs7517847 had the strongest association to CD. In a very recent British study, in contrast, the strongest association to CD was found for rs11209026 (p.Arg381Gln) [13], while another genome-wide association study from Belgium identified (in addition to rs11209026) rs11465804 as the strongest CD-associated marker [42]. Overall, these studies confirm IL23R as a CD susceptibility gene, but demonstrate differences for certain IL23R variants regarding the strength of their disease-modifying effect in different populations.
###end p 49
###begin p 50
###xml 90 95 90 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 134 139 134 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 259 265 259 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15</italic>
###xml 361 365 361 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 475 479 475 479 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
Importantly, our study also revealed similar, but markedly weaker associations of several IL23R SNPs with UC, suggesting that certain IL23R variants may also contribute to the pathogenesis of UC which is not the case for the other main CD susceptibility gene CARD15. As these SNPs were not completely consistent to those found in the previous genome-wide study [12], it has to be acknowledged that the present study included only cases with sporadic UC, whereas Duerr et al. [12] investigated familial UC.
###end p 50
###begin p 51
###xml 73 78 73 78 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 121 122 121 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 146 147 146 147 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 513 517 513 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Duerr1">[12]</xref>
###xml 588 593 588 593 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 749 754 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 889 890 889 890 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 899 901 899 901 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;8</sup>
###xml 913 916 913 916 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;11</sup>
###xml 918 922 918 922 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Tremelling1">[13]</xref>
###xml 1469 1474 1469 1474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 1090 1098 <span type="species:ncbi:9606">patients</span>
###xml 1185 1192 <span type="species:ncbi:9606">patient</span>
###xml 1227 1235 <span type="species:ncbi:9606">patients</span>
A detailed genotype-phenotype analysis revealed weak associations of the IL23R rs1004819 variant with ileal involvement (P = 0.004) and stenoses (P = 0.045) in carriers of the TT genotype compared to carriers of the CC wildtype genotype. However, both associations did not fulfill significance criteria after Bonferroni correction. Nevertheless, the prevalence of ileal involvement in carriers of the TT genotype of the rs1004819 variant (93.2%) was remarkable high. Given that the original study by Duerr et al. [12] analyzed only ileal cases of CD, it has been assumed that some of the IL23R variants may predispose to an ileal disease phenotype. However, a very recent British study could not identify a certain disease phenotype associated with IL23R variants but the strength of the association between CD and the rs1004819 variant was almost 1000fold weaker than in our study group (P = 1.1x10-8 vs. 1.92x10-11) [13] which may partly explain the different results of these two genotype-phenotype analyses. It has to be acknowledged that our genotype-phenotype analysis was limited to patients with detailed phenotype status available which were all part of the Munich IBD center patient population. Moreover, none of the patients included in the phenotype analysis was homozygous for the AA genotype of the rs11209026 variant. Therefore, it can not be excluded that larger multicenter trials or metaanalyses may reveal a certain disease phenotype associated with IL23R variants.
###end p 51
###begin p 52
###xml 15 20 15 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 331 335 331 335 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Cargill1">[43]</xref>
###xml 348 352 348 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Mannon1">[44]</xref>
###xml 367 371 367 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Krueger1">[45]</xref>
###xml 464 469 464 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 683 688 683 688 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 776 780 776 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Zhang1">[46]</xref>
Interestingly, IL23R was also identified as a disease-associated gene in other chronic inflammatory diseases. The rs10489629 variant was found to be associated with chronic periodontitis (Glas et al., unpublished data), while in psoriasis, a predisposing haplotype including the p.Arg381Gln variant (rs11209026) has been described [43]. In both CD [44] and psoriasis [45], treatment with an anti-p40 IL-12/23 antibody demonstrated therapeutic efficacy. Therefore, IL23R potentially represents a susceptibility gene and therapeutic target in various chronic inflammatory diseases. However, the degree and the variety of associated SNPs may differ in the different diseases. Possibly, IL23R variants result in alternative mRNA splicing, leading to corresponding IL-23R isoforms [46] with different tissue distributions. Functional studies will be necessary to clarify this issue.
###end p 52
###begin p 53
###xml 60 64 60 64 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Mannon1">[44]</xref>
###xml 224 228 224 228 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Neurath2">[47]</xref>
###xml 230 234 230 234 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Simpson1">[48]</xref>
###xml 407 411 407 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Hue1">[23]</xref>
###xml 413 417 413 417 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Elson1">[28]</xref>
###xml 540 544 540 544 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Samoilova1">[49]</xref>
###xml 615 619 615 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Brand3">[50]</xref>
###xml 621 625 621 625 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Brand4">[51]</xref>
###xml 664 668 664 668 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Zheng1">[52]</xref>
###xml 729 733 729 733 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Brand4">[51]</xref>
###xml 884 888 884 888 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Becker1">[22]</xref>
###xml 51 56 <span type="species:ncbi:9606">human</span>
###xml 256 260 <span type="species:ncbi:10090">mice</span>
###xml 829 833 <span type="species:ncbi:10090">mice</span>
Supporting the results of the first pilot study in human CD [44], neutralizing antibodies to the p40 subunit, which block both IL-12 and IL-23, suppressed established chronic intestinal inflammation in an animal model of CD [47], [48]. Studies in knockout mice and the efficacy of antibodies against the IL-23-specific p19 subunit suggest that IL-23 rather than IL-12 drives chronic intestinal inflammation [23], [28]. The T-cell response activated by IL-23 is attenuated by SOCS3, which acts as a feedback inhibitor to regulate Th17 cells [49]. Interestingly, we recently demonstrated activation of STAT3 by IL-22 [50], [51], which is also produced in Th17 cells [52], and attenuation of IL-22 signaling by SOCS3 overexpression [51]. Although selective targeting of IL-23 is now emerging as an attractive concept, p19-deficient mice are highly susceptible to T cell-mediated colitis [22].
###end p 53
###begin p 54
###xml 164 169 164 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 361 368 361 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ATG16L1</italic>
###xml 368 372 368 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Rioux1">[41]</xref>
###xml 374 378 374 378 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Libioulle1">[42]</xref>
###xml 380 384 380 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Hampe2">[53]</xref>
###xml 386 392 386 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PHOX2B</italic>
###xml 394 398 394 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">NCF4</italic>
###xml 400 406 400 406 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">FAM92B</italic>
###xml 406 410 406 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Rioux1">[41]</xref>
###xml 436 442 436 442 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">PTGER4</italic>
###xml 454 458 454 458 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Libioulle1">[42]</xref>
###xml 840 844 840 844 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Seiderer1">[37]</xref>
###xml 846 850 846 850 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Seiderer2">[38]</xref>
###xml 1005 1013 1005 1013 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="supplementary-material" rid="pone.0000819.s006">Table S6</xref>
###xml 1156 1159 1156 1159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Peltekova1">[8]</xref>
###xml 1161 1165 1161 1165 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="pone.0000819-Torok1">[10]</xref>
###xml 1223 1228 1223 1228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 1333 1338 1333 1338 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 1381 1397 1381 1397 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">SLC22A4, SLC22A5</italic>
###xml 1402 1408 1402 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15</italic>
Despite the successful proof of principle for the applicability of genome-wide association studies in the genetics of complex diseases, the contribution of certain IL23R variants to CD or UC is not sufficiently strong to explain the genetic background of IBD on its own. Other candidate genes are likely to be involved and recent genome wide scans suggest also ATG16L1[41], [42], [53], PHOX2B, NCF4, FAM92B[41], and a region modulating PTGER4 expression [42] as CD susceptibility genes, but further confirmatory studies are necessary. In contrast, a multitude of studies demonstrated that certain NOD2 variants, particularly p.Arg702Trp, p.Gly908Arg, and p.Leu1007fsX1008, are associated with CD, but not with UC. We and others demonstrated a strong association with an ileal disease phenotype particularly for the p.Leu1007fsX1008 variant [37], [38]. Interestingly, in this study, p.Leu1007fsX1008 was the most strongly CD-associated gene variant in a combined multivariate analysis (Supplementary Data, Table S6). The other CD susceptibility gene repeatedly confirmed is located within the IBD5 locus and most likely represented by certain OCTN variants [8], [10]. We therefore also investigated possible interactions of IL23R variants with these IBD susceptibility genes. We could not demonstrate an epistatic interaction between IL23R variants and the analyzed variants in the SLC22A4, SLC22A5 and CARD15 genes on IBD susceptibility but demonstrated for some gene variants an epistatic influence on certain disease characteristics. However, these interactions lost significance after Bonferroni correction.
###end p 54
###begin p 55
###xml 47 52 47 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 93 98 93 98 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
###xml 369 393 369 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">CARD15, SLC22A4, SLC22A5</italic>
###xml 430 435 430 435 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">IL23R</italic>
In conclusion, we confirmed the association of IL23R with IBD. In addition to the protective IL23R variant rs11209026 (p.Arg381Gln), we identified rs1004819 as independent risk factor for developing CD and UC in the German population which may also contribute to an ileal disease phenotype in CD. A combined analysis of variants in three other CD susceptibility genes (CARD15, SLC22A4, SLC22A5) found no evidence for epistasis to IL23R regarding CD susceptibility.
###end p 55
###begin title 56
Supporting Information
###end title 56
###begin p 57
(0.04 MB DOC)
###end p 57
###begin p 58
Click here for additional data file.
###end p 58
###begin p 59
(0.03 MB DOC)
###end p 59
###begin p 60
Click here for additional data file.
###end p 60
###begin p 61
(0.07 MB DOC)
###end p 61
###begin p 62
Click here for additional data file.
###end p 62
###begin p 63
(0.04 MB DOC)
###end p 63
###begin p 64
Click here for additional data file.
###end p 64
###begin p 65
(0.04 MB DOC)
###end p 65
###begin p 66
Click here for additional data file.
###end p 66
###begin p 67
(0.03 MB DOC)
###end p 67
###begin p 68
Click here for additional data file.
###end p 68
###begin title 69
References
###end title 69
###begin article-title 70
Inflammatory bowel disease.
###end article-title 70
###begin article-title 71
Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis.
###end article-title 71
###begin article-title 72
A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.
###end article-title 72
###begin article-title 73
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease.
###end article-title 73
###begin article-title 74
The role of Toll-like receptor 4 Asp299Gly and Thr399Ile polymorphisms and CARD15/NOD2 mutations in the susceptibility and phenotype of Crohn's disease.
###end article-title 74
###begin article-title 75
Increased expression of the chemokine fractalkine in Crohn's disease and association of the fractalkine receptor T280M polymorphism with a fibrostenosing disease phenotype.
###end article-title 75
###begin article-title 76
###xml 151 159 <span type="species:ncbi:9606">patients</span>
Macrophage migration inhibitory factor (MIF) -173G/C promoter polymorphism influences upper gastrointestinal tract involvement and disease activity in patients with Crohn's disease.
###end article-title 76
###begin article-title 77
Functional variants of OCTN cation transporter genes are associated with Crohn disease.
###end article-title 77
###begin article-title 78
###xml 88 96 <span type="species:ncbi:9606">patients</span>
Eight novel CARD15 variants detected by DNA sequence analysis of the CARD15 gene in 111 patients with inflammatory bowel disease.
###end article-title 78
###begin article-title 79
Polymorphisms in the DLG5 and OCTN cation transporter genes in Crohn's disease.
###end article-title 79
###begin article-title 80
Role of the NFKB1 -94ins/delATTG promoter polymorphism in IBD and potential interactions with polymorphisms in the CARD15/NOD2, IKBL, and IL-1RN genes.
###end article-title 80
###begin article-title 81
A genome-wide association study identifies IL23R as an inflammatory bowel disease gene.
###end article-title 81
###begin article-title 82
IL23R variation determines susceptibility but not disease phenotype in inflammatory bowel disease.
###end article-title 82
###begin article-title 83
IL-23 receptor (IL-23R) gene protects against pediatric Crohn's disease.
###end article-title 83
###begin article-title 84
IL23R Arg381Gln is associated with childhood onset inflammatory bowel disease in Scotland.
###end article-title 84
###begin article-title 85
TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells.
###end article-title 85
###begin article-title 86
IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways.
###end article-title 86
###begin article-title 87
IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells.
###end article-title 87
###begin article-title 88
Essential autocrine regulation by IL-21 in the generation of inflammatory T cells.
###end article-title 88
###begin article-title 89
IL-23: a master regulator in Crohn disease.
###end article-title 89
###begin article-title 90
IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6.
###end article-title 90
###begin article-title 91
Cutting edge: IL-23 cross-regulates IL-12 production in T cell-dependent experimental colitis.
###end article-title 91
###begin article-title 92
Interleukin-23 drives innate and T cell-mediated intestinal inflammation.
###end article-title 92
###begin article-title 93
IL-23 promotes tumour incidence and growth.
###end article-title 93
###begin article-title 94
Immune enhancement and anti-tumour activity of IL-23.
###end article-title 94
###begin article-title 95
IL-23 is critical in the induction but not in the effector phase of experimental autoimmune encephalomyelitis.
###end article-title 95
###begin article-title 96
IL-23 is increased in dendritic cells in multiple sclerosis and down-regulation of IL-23 by antisense oligos increases dendritic cell IL-10 production.
###end article-title 96
###begin article-title 97
###xml 85 89 <span type="species:ncbi:10090">mice</span>
Monoclonal anti-interleukin-23 reverses active colitis in a T cell-mediated model in mice.
###end article-title 97
###begin article-title 98
Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody.
###end article-title 98
###begin article-title 99
Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells.
###end article-title 99
###begin article-title 100
CX3CR1-mediated dendritic cell access to the intestinal lumen and bacterial clearance.
###end article-title 100
###begin article-title 101
###xml 100 106 <span type="species:ncbi:10090">murine</span>
TLR-ligand stimulated interleukin-23 subunit expression and assembly is regulated differentially in murine plasmacytoid and myeloid dendritic cells.
###end article-title 101
###begin article-title 102
Dependence of intestinal granuloma formation on unique myeloid DC-like cells.
###end article-title 102
###begin article-title 103
Genetics. Delivering new disease genes.
###end article-title 103
###begin article-title 104
Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations.
###end article-title 104
###begin article-title 105
The contribution of OCTN1/2 variants within the IBD5 locus to disease susceptibility and severity in Crohn's disease.
###end article-title 105
###begin article-title 106
Homozygosity for the CARD15 frameshift mutation 1007fs is predictive of early onset of Crohn's disease with ileal stenosis, entero-enteral fistulas, and frequent need for surgical intervention with high risk of re-stenosis.
###end article-title 106
###begin article-title 107
Predictive value of the CARD15 variant 1007fs for the diagnosis of intestinal stenoses and the need for surgery in Crohn's disease in clinical practice: results of a prospective study.
###end article-title 107
###begin article-title 108
Classification of inflammatory bowel disease.
###end article-title 108
###begin article-title 109
Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology.
###end article-title 109
###begin article-title 110
Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis.
###end article-title 110
###begin article-title 111
Novel Crohn Disease Locus Identified by Genome-Wide Association Maps to a Gene Desert on 5p13.1 and Modulates Expression of PTGER4.
###end article-title 111
###begin article-title 112
A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes.
###end article-title 112
###begin article-title 113
Anti-interleukin-12 antibody for active Crohn's disease.
###end article-title 113
###begin article-title 114
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human interleukin-12/23 monoclonal antibody for the treatment of psoriasis.
###end article-title 114
###begin article-title 115
After interleukin-12p40, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
###end article-title 115
###begin article-title 116
###xml 74 78 <span type="species:ncbi:10090">mice</span>
Antibodies to interleukin 12 abrogate established experimental colitis in mice.
###end article-title 116
###begin article-title 117
T cell-mediated pathology in two models of experimental colitis depends predominantly on the interleukin 12/Signal transducer and activator of transcription (Stat)-4 pathway, but is not conditional on interferon gamma expression by T cells.
###end article-title 117
###begin article-title 118
###xml 15 19 <span type="species:ncbi:10090">mice</span>
IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells.
###end article-title 118
###begin article-title 119
IL-22 is increased in active Crohn's disease and promotes proinflammatory gene expression and intestinal epithelial cell migration.
###end article-title 119
###begin article-title 120
IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
###end article-title 120
###begin article-title 121
Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis.
###end article-title 121
###begin article-title 122
A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1.
###end article-title 122
###begin p 123
###xml 0 21 0 21 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Competing Interests: </bold>
Competing Interests: The authors have declared that no competing interests exist.
###end p 123
###begin p 124
###xml 0 9 0 9 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Funding: </bold>
Funding: J. Seiderer and J. Dambacher were supported by grants from the University of Munich (FoFoLe Nr. 422; Habilitationsstipendium to J.S. and Promotionsstipendium to J.D.). A. Konrad was supported by grants of the Deutsche Forschungsgemeinschaft (DFG; KO 2228/4-1). J. Glas and H.-P. Torok were supported by a grant from the Broad Medical Foundation (IBD-0126R2). S. Brand was supported by grants from the DFG (BR 1912/5-1) and the Else-Kroner-Fresenius-Stiftung (P50/05/EKMS05/62) and by the Ludwig-Demling Grant 2007 from DCCV e.V. This work contains parts of the unpublished degree theses of M. Wetzke and J. Dambacher. We thank B. Salil for excellent technical support. Design and conduct of the study, collection, analysis, interpretation of the data, preparation, review and approval of the manuscript were completely independent of the sponsors of this study.
###end p 124

